Advanced search
Publication Cover
Future Science OA Volume 4, 2018 - Issue 9
Submit an article Journal homepage
1,083
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Survival and Glycemic Control in Patients With Colorectal Cancer and Diabetes Mellitus

Nina J Karlin1 Division of Hematology and Medical Oncology, Mayo Clinic Hospital, Phoenix, AZ85054, USACorrespondence[email protected]
,
Shailja B Amin1 Division of Hematology and Medical Oncology, Mayo Clinic Hospital, Phoenix, AZ85054, USA
,
Heidi E Kosiorek2 Biostatistics, Mayo Clinic Hospital, Phoenix, AZ85054, USA
,
Matthew R Buras2 Biostatistics, Mayo Clinic Hospital, Phoenix, AZ85054, USA
,
Patricia M Verona3 Department of Information Technology, Mayo Clinic Hospital, Phoenix, AZ85054, USA
&
Curtiss B Cook4 Division of Endocrinology, Mayo Clinic, Scottsdale, AZ85259, USA;5 Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, Scottsdale, AZ85259, USA
Article: FSO335 | Received 12 Apr 2018, Accepted 16 Jul 2018, Published online: 15 Aug 2018

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J. Clin. 66(1), 7–30 (2016).
  • GBd mortality and causes of death collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385(9963), 117–171 (2015).
  • Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J. Clin. 59(6), 366–378 (2009).
  • Sharma A, Ng H, Kumar A et al. Colorectal cancer: histopathologic differences in tumor characteristics between patients with and without diabetes. Clin. Colorectal Cancer 13(1), 54–61 (2014).
  • Gonzalez N, Prieto I, Del Puerto-Nevado L et al. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget 8(11), 18456–18485 (2017).
  • Rosato V, Tavani A, Gracia-Lavedan E et al. Type 2 diabetes, antidiabetic medications, and colorectal cancer risk: two case–control studies from Italy and Spain. Front. Oncol. 6, 210 (2016).
  • de Kort S, Simons CC, van den Brandt PA et al. Diabetes mellitus Type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer. Eur. J. Gastroenterol. Hepatol. 28(8), 896–903 (2016).
  • de Kort S, Masclee AAM, Sanduleanu S et al. Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation. Sci. Rep. 7, 46527 (2017).
  • Zhu B, Wu X, Wu B, Pei D, Zhang L, Wei L. The relationship between diabetes and colorectal cancer prognosis: a meta-analysis based on the cohort studies. PLoS ONE 12(4), e0176068 (2017).
  • Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G. Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis. Colon Rectum 56(11), 1304–1319 (2013).
  • Luo J, Lin HC, He K, Hendryx M. Diabetes and prognosis in older persons with colorectal cancer. Br. J. Cancer 110(7), 1847–1854 (2014).
  • Jullumstro E, Kollind M, Lydersen S, Edna TH. Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol. 48(3), 361–367 (2009).
  • Noh GY, Hwang DY, Choi YH, Lee YY. Effect of diabetes mellitus on outcomes of colorectal cancer. J. Korean Soc. Coloproctol. 26(6), 424–428 (2010).
  • Karlin NJ, Dueck AC, Cook CB. Cancer with diabetes: prevalence, metabolic control and survival in an academic oncology practice. Endocr. Pract. 18(6), 898–905 (2012).
  • Karlin NJ, Dueck AC, Nagi Reddy SK, Verona PM, Cook CB. Implications of breast cancer with diabetes mellitus on patient outcomes and care. Diabetes Manag. (Lond.) 4(5), 411–419 (2014).
  • Karlin NJ, Amin SB, Verona PM, Kosiorek HE, Cook CB. Co-existing prostate cancer and diabetes mellitus: implications for patient outcomes and care. Endocr. Pract. 23(7), 816–821 (2017).
  • Karlin NJ, Amin SB, Buras MR, Kosiorek HE, Verona PM, Cook CB. Patient outcomes from lung cancer and diabetes mellitus: a matched case–control study. Future Sci. OA 4(1), FSO248 (2018).
  • Karlin NJ, Amin SB, Kosiorek HE, Buras MR, Verona PM, Cook CB. Survival and glycemic control outcomes among patients with coexisting pancreatic cancer and diabetes mellitus. Future Sci. OA 4(4), FSO291 (2018).
  • Faries DE, Haro JM, Leon AC. Analysis of Observational Healthcare Data Using SAS. SAS, Cary, NC, USA (2010).
  • Zayed AA, Beano AM, Amer FN et al. Serum levels of carcinoembryonic antigen in patients with Type 2 diabetes. Endocr. Pract. 22(11), 1310–1318 (2016).
  • Shang X, Song C, Du X, Shao H, Xu D, Wang X. The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control. Saudi Med. J. 38(2), 204–208 (2017).
  • Ata N, Dal K, Kucukazman M et al. The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels. Open Med. (Wars.) 10(1), 8–13 (2015).
  • Hasan M, Mohieldein A. Association between serum carcinoembryonic antigen level and oxidative stress parameters among diabetic females. Int. J. Clin. Exp. Med. 8(4), 6489–6494 (2015).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.